SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Iman H Nasr, Ania L Manson, Humaid A Al Wahshi, Hilary J Longhurst, Optimizing hereditary angioedema management through tailored treatment approaches, Expert Review of Clinical Immunology, 2016, 12, 1, 19

    CrossRef

  2. 2
    Teresa Caballero Molina, María Pedrosa Delgado, Carmen Gómez Traseira, Angioedema hereditario, Medicina Clínica, 2015, 145, 8, 356

    CrossRef

  3. 3
    A. Ghannam, P. Sellier, F. Defendi, B. Favier, D. Charignon, A. López-Lera, M. López-Trascasa, D. Ponard, C. Drouet, C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay, Allergy, 2015, 70, 9
  4. 4
    Konrad Bork, Currently available treatments and future treatment options for hereditary angioedema, Allergo Journal, 2015, 24, 4, 32

    CrossRef

  5. 5
    Konrad Bork, Currently available treatments and future treatment options for hereditary angioedema, Allergo Journal International, 2015, 24, 4, 122

    CrossRef

  6. 6
    A. Reshef, A. Zanichelli, H. Longhurst, A. Relan, C. E. Hack, Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk, Allergy, 2015, 70, 5
  7. 7
    Geetika Sabharwal, Timothy Craig, Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE), Expert Review of Clinical Immunology, 2015, 11, 3, 319

    CrossRef

  8. 8
    Marc Riedl, Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema, Clinical Drug Investigation, 2015, 35, 7, 407

    CrossRef

  9. 9
    Dumitru Moldovan, Jonathan A Bernstein, Marco Cicardi, Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency, Immunotherapy, 2015, 7, 7, 739

    CrossRef

  10. 10
    Henriette Farkas, Kinga Viktoria Kohalmi, Nora Veszeli, Zsuzsanna Zotter, Lilian Varga, Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema, Annals of Allergy, Asthma & Immunology, 2015, 114, 1, 64

    CrossRef

  11. 11
    Giuliana Ferrante, Valeria Scavone, Maria Muscia, Emilia Adrignola, Giovanni Corsello, Giovanni Passalacqua, Stefania La Grutta, The care pathway for children with urticaria, angioedema, mastocytosis, World Allergy Organization Journal, 2015, 8, 1, 5

    CrossRef

  12. 12
    Konrad Bork, An evidence based therapeutic approach to hereditary and acquired angioedema, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 354

    CrossRef

  13. 13
    W. Aberer, Angioedema is not just ‘deep urticaria’ but an entity of its own, Allergy, 2014, 69, 5
  14. 14
    M. Magerl, G. Doumoulakis, I. Kalkounou, K. Weller, M. K. Church, W. Kreuz, M. Maurer, Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema, Clinical and Experimental Dermatology, 2014, 39, 3
  15. 15
    Marc A. Riedl, Jonathan A. Bernstein, Henry Li, Avner Reshef, William Lumry, Dumitru Moldovan, Henriette Farkas, Robyn Levy, James Baker, Yun Hardiman, Mark C. Totoritis, Anurag Relan, Marco Cicardi, Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial, Annals of Allergy, Asthma & Immunology, 2014, 112, 2, 163

    CrossRef

  16. 16
    Geneviève Gavigan, William H Yang, Stephanie Santucci, Rachel Harrison, Jacob Karsh, The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study, Allergy, Asthma & Clinical Immunology, 2014, 10, 1, 17

    CrossRef

  17. 17
    C. Schlapbach, D. Simon, Update on skin allergy, Allergy, 2014, 69, 12
  18. 18
    G. Porebski, Avner Reshef, Dumitru Moldovan, The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?, Allergy, 2013, 68, 9
  19. 19
    Andrea Zanichelli, Marta Mansi, Giulia Periti, Marco Cicardi, Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency, Expert Review of Clinical Immunology, 2013, 9, 5, 477

    CrossRef